Could Alcon (ALC) and RxSight (RXST)’s Partnership Reshape the Future of Cataract Surgery?
Could Alcon (ALC) and RxSight (RXST)’s Partnership Reshape the Future of Cataract Surgery? Laiba Immad Thu, August 13, 2026 at 3:49 PM PDT 5 min read ALC RXST Two ophthalmic technology leaders, Alcon Inc. (NYSE: ALC ) and RxSight, Inc. (NASDAQ: RXST ), earlier on July 6 entered into a strategic collaboration that highlights the evolving landscape of cataract and refractive surgery. The companies announced a non-exclusive pact to co-develop post-operatively adjustable pseudophakic intraocular lenses (PCIOLs). By pairing RxSight's proprietary light-adjustable technology, which allows eye surgeons to fine-tune a patient's vision using UV light after surgery, with Alcon's global commercial footprint and surgical equipment portfolio, the agreement validates RxSight's technology while expanding Alcon's premium lens offerings. Concurrently, Alcon Inc. has strengthened its international presence by opening its second training center in partnership with the Aravind Eye Care...
Comments
Post a Comment